Go Pro
→ Why This Small AI Company Holds 150 Patents (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
$0.00
$0.00
▼
$0.01
N/AN/A158,122 shsN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.95
+0.6%		$1.51
$0.91
▼
$46.50
$6.56M2.85217,120 shs406,601 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-0.05%-14.52%-25.37%-72.10%-92.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
$0.00
$0.00
▼
$0.01
N/AN/A158,122 shsN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.95
+0.6%		$1.51
$0.91
▼
$46.50
$6.56M2.85217,120 shs406,601 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-0.05%-14.52%-25.37%-72.10%-92.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
0.00
N/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
2.50
Moderate Buy$67.507,037.57% Upside

Current Analyst Ratings Breakdown

Latest KIBO, BION, NZI, and CODX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2026
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/18/2026
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
Maxim Group logo
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 9/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$620K10.65N/AN/A$9.14 per share0.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$46.90M-$10.32N/AN/AN/A-6,531.77%-210.99%-174.97%11/5/2026 (Estimated)

Latest KIBO, BION, NZI, and CODX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$3.00-$1.46+$1.54-$1.46$0.13 million$0.17 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
1.81
1.52

Institutional Ownership

CompanyInstitutional Ownership
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%

Insider Ownership

CompanyInsider Ownership
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bio Nitrogen Hldgs stock logo
BION
Bio Nitrogen Hldgs
N/AN/AN/ANot Optionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
1006.98 million6.82 millionNo Data

Recent News About These Companies

Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX) and Amgen (AMGN)
 |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CODX/pressreleases/4679581/analysts-offer-insights-on-healthcare-companies-co-diagnostics-codx-and-amgen-amgn/
Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026
September 17 at 1:20 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/co-diagnostics-participate-joint-unitaid-130000566.html
Co-Diagnostics, ReadyGo Advance Blood-Based Ebola Testing At The Point Of Need; Stock Down
September 16 at 5:17 PM  |  rttnews.comhttps://www.rttnews.com/3691549/co-diagnostics-readygo-advance-blood-based-ebola-testing-at-the-point-of-need-stock-down.aspx
Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Call Transcript
September 16 at 4:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4947101-co-diagnostics-inc-codx-shareholder-analyst-call-transcript
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
September 16 at 8:45 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-and-readygo-collaborate-to-evaluate-blood-based-molecular-testing-at-the-point-of-need-starting-with-ebola-302880383.html
Co-Diagnostics to Hold Press Conference
September 15 at 4:15 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-to-hold-press-conference-302879628.html
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
September 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-completes-new-vector-smart-laboratory-installations-amid-rising-dengue-activity-in-florida-302874606.html
Co-Diagnostics Appoints New Principal Financial Officer
September 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/co-diagnostics-appoints-new-principal-financial-officer?utm_source=marketbeat.com&utm_medium=referral
Co-Diagnostics Adjourns Annual Meeting, Sets New Date
September 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/co-diagnostics-adjourns-annual-meeting-sets-new-date?utm_source=marketbeat.com&utm_medium=referral
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
September 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-launches-integrated-cloud-and-mobile-infrastructure-in-india-302868532.html
Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
September 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-expands-vector-smart-customer-reach-with-first-international-installation-in-usaf-base-302865873.html
Co-Dx (CODX) Q2 2026 Earnings Call Transcript
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/co-dx-codx-q2-2026-235014355.html
Positive Report for Co-Diagnostics (CODX) from Maxim Group
August 20, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CODX/pressreleases/3927328/positive-report-for-co-diagnostics-codx-from-maxim-group/
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
August 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-participates-in-medical-devices-and-innovations-roundtable-media-event-302853820.html
Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936453-co-diagnostics-inc-codx-q2-2026-earnings-call-transcript
Co-Diagnostics outlines FDA dual 510(k) and CLIA waiver submission as cash falls to $3.6M
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4632962-co-diagnostics-outlines-fda-dual-510-k-and-clia-waiver-submission-as-cash-falls-to-3_6m
Co-Diagnostics (CODX) Stock Falls on Q2 2026 Earnings
August 13, 2026  |  quiverquant.comQ
Co-Diagnostics Reports Second Quarter 2026 Financial Results
August 13, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-reports-second-quarter-2026-financial-results-302851294.html
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
August 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/co-diagnostics-submits-fda-510k-premarket-notification-for-upper-respiratory-point-of-care-test-302844796.html
Why Is Co-Diagnostics (NASDAQ:CODX) In Focus After Its Latest Molecular Diagnostics Update?
July 31, 2026  |  kalkinemedia.comK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bio Nitrogen Hldgs stock logo

Bio Nitrogen Hldgs OTCMKTS:BION

BioNitrogen Holdings Corp. engages in the manufacture of fertilizers through the conversion of agricultural biomass. It focuses on building turnkey manufacturing facilities to produce urea fertilizer, urea ammonium nitrate, melamine, and diesel exhaust fluid. The company was founded by Mario G. Beruvides on September 16, 1990 and is headquartered in Doral, FL.

Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.95 +0.01 (+0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$0.99 +0.05 (+5.11%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas